Pedro Segui
Cordoba, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Unveiling Endotypes in Systemic Lupus Erythematosus Through Multi-Omic Analysis: Insights into Cardiovascular and Renal Complications.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 01, 2025
Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 15, 2023
Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: July 29, 2021
Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
Journal: Annals of the rheumatic diseases
Published: March 08, 2021
Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: December 28, 2020
Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: February 16, 2017
Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.
Journal: Journal of autoimmunity
Published: January 17, 2017
Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: September 27, 2014
Last Updated: 09/26/2026